Lexaria Bioscience is advancing GLP-1 drug delivery, aiming to improve effectiveness and reduce side effects for this fast-growing market.

The Fund is a split share corporation designed to provide investors with exposure to six Canadian banks and utilizes Mulvihill Capital's proprietary covered call writing strategy to enhance the income generated by the portfolio and to reduce volatility.

Vizsla Silver is advancing toward becoming a top global silver producer with its high-grade Panuco project in Mexico, backed by strong infrastructure and a recent PEA.

Discover how Novarc Technologies' robotic solutions are transforming welding productivity and safety across the globe.